Literature DB >> 7693984

Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

M Roach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7693984     DOI： 10.1016/s0022-5347(17)35937-2

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  28 in total

1.  Correlation of endorectal coil magnetic resonance imaging of the prostate with pathologic stage.

Authors:  Stephen A Brassell; William R Krueger; Jong-Ho Choi; John A Taylor
Journal:  World J Urol       Date:  2004-09-09       Impact factor: 4.226

Review 2.  Imaging of distant metastases of prostate cancer.

Authors:  Filippo Pesapane; Marcin Czarniecki; Matteo Basilio Suter; Baris Turkbey; Geert Villeirs
Journal:  Med Oncol       Date:  2018-09-14       Impact factor: 3.064

3.  [Probability of seminal vesicle involvement in localized prostatic carcinoma. Significance in conformal radiotherapy].

Authors:  H J Feldmann; J Breul; F Zimmermann; S Wachter; T Wiegel
Journal:  Strahlenther Onkol       Date:  1998-11       Impact factor: 3.621

4.  Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer.

Authors:  Bettina Hentschel; Wolfgang Oehler; Dirk Strauss; Andreas Ulrich; Ansgar Malich
Journal:  Strahlenther Onkol       Date:  2011-02-24       Impact factor: 3.621

5.  Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy?

Authors:  G Eminowicz; C Dean; O Shoffren; N Macdougall; P Wells; R Muirhead
Journal:  Br J Radiol       Date:  2014-03-20       Impact factor: 3.039

6.  Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.

Authors:  Mack Roach; Jennifer Moughan; Colleen A F Lawton; Adam P Dicker; Kenneth L Zeitzer; Elizabeth M Gore; Young Kwok; Michael J Seider; I-Chow Hsu; Alan C Hartford; Eric M Horwitz; Kosj Yamoah; Christopher U Jones; Jeff M Michalski; W Robert Lee; Thomas M Pisansky; Rachel Rabinovitch; Marvin Rotman; Rodger M Pryzant; Harold E Kim; Charles R Thomas; William U Shipley; Howard M Sandler
Journal:  Lancet Oncol       Date:  2018-10-10       Impact factor: 41.316

7.  Significance of examined lymph-node count in accurate staging and long-term survival in patients undergoing radical prostatectomy: a population-based study.

Authors:  Cheng Chen; Jie Shen; Zhaoyu Xing; Changchuan Jiang; Linkun Hu; Li Cui; Dong Xue; Xiaozhou He; Renfang Xu
Journal:  Int Urol Nephrol       Date:  2019-09-30       Impact factor: 2.370

Review 8.  Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm.

Authors:  Gilles Créhange; Chien Peter Chen; Charles C Hsu; Norbert Kased; Fergus V Coakley; John Kurhanewicz; Mack Roach
Journal:  Cancer Treat Rev       Date:  2012-06-15       Impact factor: 12.111

9.  Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials.

Authors:  George Rodrigues; Kyounghwa Bae; Mack Roach; Colleen Lawton; Bryan Donnelly; David Grignon; Gerald Hanks; Arthur Porter; Herbert Lepor; Howard Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-24       Impact factor: 7.038

10.  Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.

Authors:  Jeff M Michalski; Kyounghwa Bae; Mack Roach; Arnold M Markoe; Howard M Sandler; Janice Ryu; Matthew B Parliament; William Straube; Richard K Valicenti; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.